The Cannabis ETF (THCX)
ARCA ARCA Primary 
April 2025 Ancillary Cannabis Stock Watchlist: Three Companies Powering the Industry
As the cannabis market expands across the United States, ancillary companies are stepping into the spotlight. These companies provide essential services and products to cannabis growers and retailers without touching the plant itself. Therefore, they can offer exposure to the sector without the same regulatory risks. Today, we explore three top ancillary cannabis stocks to watch in March 2025.
Have Cannabis Investors Been Early Or Wrong Or Both?
The cannabis sector faces significant challenges, including political stagnation, lack of new state markets, and competition from the intoxicating hemp market. Leef Brands' Jesse Redmond on expanding in California and entering the New York market to improve margins and growth.
April 2025's Canadian Cannabis Stock Picks: Growth and Opportunity
As the U.S. cannabis industry continues to grow, Canadian cannabis stocks are gaining momentum with investors. The U.S. market is expected to reach over $44 billion in 2025. By 2030, analysts believe it could climb to more than $75 billion. Adult-use cannabis is now legal in nearly half of the U.S. states. Many others permit medical use, creating widespread demand. At the same time, lawmakers are again discussing federal reform bills. These bills aim to provide national guidelines and unlock interstate trade. Although legalization has faced delays, investor sentiment remains optimistic. Canadian companies are preparing to scale their U.S. operations once laws change.
Best Cannabis Infrastructure Stocks to Buy in 2025
The U.S. cannabis industry continues to expand rapidly. Experts estimate the market will exceed $45 billion in annual revenue by 2025. This growth is fueled by consumer demand, increasing dispensary presence, and employment surges across cultivation and retail sectors. Most Americans now live near a licensed cannabis store, and the industry employs hundreds of thousands. While federal legalization remains pending, significant momentum is building. Recent federal efforts to reclassify cannabis could reduce restrictions and tax burdens. These changes would directly benefit ancillary businesses supporting cultivation and distribution. Therefore, many investors are closely watching this space for early opportunities.
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?
Not your typical cannabis play. Discover why Jazz Pharma's FDA-approved CBD drug could make it a top cannabis stock to watch in 2025.
Top Cannabis Stocks In The Public Sector 2025
Most cannabis stock investors are stuck in a unique position in the sector. To start, most publicly traded cannabis companies are down and have been for some time. With all that is occurring across the stock market due to the tariffs, new concerns are further to grow. No one knows exactly how this will impact marijuana stocks and the future of the cannabis industry. People are trying to make the best choices on where to stay calm, cut their losses, or double down on how low the sector has fallen.
April 2025 Watchlist: Leading Cannabis Stocks from Canada
The cannabis industry continues to evolve quickly, especially in the United States. In 2025, the U.S. market is expected to generate over $45 billion in revenue. This growth is fueled by expanding legalization and rising demand for both medical and recreational products. Recently, there has been momentum toward federal reform. The possibility of reclassifying cannabis to a lower drug schedule has gained support. States like New York and Maryland are also opening more dispensaries. As more legal markets emerge, Canadian cannabis companies are positioning themselves for long-term U.S. expansion. This week, several Canadian stocks are gaining attention from investors.
April 2025 Watchlist: Best Ancillary Cannabis Stocks for Growth Potential
The U.S. cannabis industry is experiencing significant growth, with legal sales projected to reach around $45 billion in 2025. Wider legalization efforts and increased consumer demand fuel this rapid expansion. Today, most Americans live in areas with at least one licensed dispensary. Recently, there has also been renewed momentum toward federal cannabis reform, with new legalization initiatives gaining traction. As these trends continue, ancillary cannabis companies are becoming key players. They supply the tools, technologies, and services that drive the industry forward without touching the plant directly.
Undervalued U.S. Cannabis Penny Stocks to Add to Your Watchlist
The U.S. cannabis industry continues to grow rapidly, creating opportunities for investors focused on penny stocks. In 2024, legal cannabis sales topped $32 billion nationwide. That number is expected to reach $45 billion by the end of 2025. This growth is fueled by new state-level legalization and rising consumer demand. Currently, adult-use cannabis is legal in nearly half the U.S. states. Even more importantly, recent headlines hint at changes at the federal level. A proposal to reclassify marijuana under federal law could ease restrictions on the industry. As a result, many investors are turning their attention to low-priced marijuana stocks. These companies often react quickly to news and momentum, offering big upside potential. However, it's critical to approach these trades with the right tools and awareness.
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue strengthening their positions in Canadian and international markets. Though based in Canada, these firms have exposure to the U.S. through strategic investments and partnerships. The U.S. cannabis industry is expected to generate over $45 billion annually by 2025. Legalization efforts are expanding, and several states are reviewing new adult-use and medical cannabis bills. At the same time, court rulings and state-level decisions continue to shape the legal landscape. Because of this, Canadian companies with U.S. exposure are drawing increased interest from traders and long-term investors alike.
March 2025 Watchlist: Top Ancillary Cannabis Stocks Poised for Growth
The U.S. cannabis industry continues expanding, creating opportunities for ancillary companies that support cultivation and retail operations the U.S. legal cannabis industry experienced significant growth, with sales reaching approximately $31.4 billion, marking a 9.14% increase from the previous year. Industry experts predict sales could reach $50 billion by 2028 as more states legalize marijuana. Recently, Congress discussed federal cannabis reform, increasing speculation about potential rescheduling. If federal legalization advances, ancillary stocks could see strong momentum. These companies provide essential products, including hydroponics, lighting, and packaging, benefiting from growing cannabis demand. As the industry evolves, investors are closely watching top-performing ancillary stocks this week.
Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?
ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.
